| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Intercept Pharmaceuticals Inc (NASDAQ: ICPT)
ICPT Technical Analysis
5
| As on 9th Jun 2023 ICPT STOCK Price closed @ 11.85 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 15.71 & Strong Sell for SHORT-TERM with Stoploss of 15.82 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ICPTSTOCK Price
| Open | 12.31 | Change | Price | % |
| High | 12.44 | 1 Day | -0.40 | -3.27 |
| Low | 11.82 | 1 Week | 1.59 | 15.50 |
| Close | 11.85 | 1 Month | -6.53 | -35.53 |
| Volume | 1043275 | 1 Year | -5.29 | -30.86 |
| 52 Week High 21.71 | 52 Week Low 9.17 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| ICPT Daily Charts |
ICPT Intraday Charts |
Whats New @ Bazaartrend |
ICPT Free Analysis |
|
|
ICPT Important Levels Intraday
| RESISTANCE | 13.04 |
| RESISTANCE | 12.66 |
| RESISTANCE | 12.42 |
| RESISTANCE | 12.19 |
| SUPPORT | 11.51 |
| SUPPORT | 11.28 |
| SUPPORT | 11.04 |
| SUPPORT | 10.66 |
ICPT Forecast April 2024
| 4th UP Forecast | 20.1 |
| 3rd UP Forecast | 17.45 |
| 2nd UP Forecast | 15.82 |
| 1st UP Forecast | 14.18 |
| 1st DOWN Forecast | 9.52 |
| 2nd DOWN Forecast | 7.88 |
| 3rd DOWN Forecast | 6.25 |
| 4th DOWN Forecast | 3.6 |
ICPT Weekly Forecast
| 4th UP Forecast | 16.44 |
| 3rd UP Forecast | 14.97 |
| 2nd UP Forecast | 14.06 |
| 1st UP Forecast | 13.15 |
| 1st DOWN Forecast | 10.55 |
| 2nd DOWN Forecast | 9.64 |
| 3rd DOWN Forecast | 8.73 |
| 4th DOWN Forecast | 7.26 |
ICPT Forecast2024
| 4th UP Forecast | 36.98 |
| 3rd UP Forecast | 28.92 |
| 2nd UP Forecast | 23.94 |
| 1st UP Forecast | 18.96 |
| 1st DOWN Forecast | 4.74 |
| 2nd DOWN Forecast | -0.24 |
| 3rd DOWN Forecast | -5.22 |
| 4th DOWN Forecast | -13.28 |
Intercept Pharmaceuticals Inc ( NASDAQ USA Symbol : ICPT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ICPT Business Profile
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. Its lead products candidate is the Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis (PBC) in combination with ursodeoxycholic acid in adults. The company is also developing Ocaliva for various indications, including nonalcoholic steatohepatitis (NASH); and other product candidates in various stages of clinical and preclinical development. It has a license agreement with Aralez Pharmaceuticals Canada Inc. to develop and commercialize bezafibrate in the United States. The company markets its products through an internal commercial organization, a contract sales organization, and third-party distributors. Intercept Pharmaceuticals, Inc. was incorporated in 2002 and is headquartered in New York, New York. Address: 10 Hudson Yards, New York, NY, United States, 10001
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service